Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eishiro Mizukoshi

Showing results (21-30 of 164) with videos related to

Pageof 17
Sort By:
International Journal of Cancer|September 10, 2009
Enhancement of tumor-specific T-cell responses by transcatheter arterial embolization with dendritic cell infusion for hepatocellular carcinomaEishiro Mizukoshi, Yasunari Nakamoto, Kuniaki Arai, et al.
Cancer Research|July 29, 2010
Antitumor effect after radiofrequency ablation of murine hepatoma is augmented by an active variant of CC Chemokine ligand 3/macrophage inflammatory protein-1alphaNoriho Iida, Yasunari Nakamoto, Tomohisa Baba, et al.
Journal of Gastroenterology|November 27, 2004
An open-label study of administration of EH0202, a health-food additive, to patients with chronic hepatitis CKyosuke Kaji, Satoshi Yoshida, Nobuo Nagata, et al.
Hepatology (Baltimore, Md.)|May 27, 2006
Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinomaEishiro Mizukoshi, Yasunari Nakamoto, Yohei Marukawa, et al.
Metabolism: Clinical and Experimental|November 14, 2007
Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virusYuki Kita, Eishiro Mizukoshi, Toshinari Takamura, et al.
Cancer Letters|September 2, 2015
Phase I trial of multidrug resistance-associated protein 3-derived peptide in patients with hepatocellular carcinomaEishiro Mizukoshi, Hidetoshi Nakagawa, Masaaki Kitahara, et al.
BMC Cancer|April 17, 2013
Peretinoin, an acyclic retinoid, improves the hepatic gene signature of chronic hepatitis C following curative therapy of hepatocellular carcinomaMasao Honda, Taro Yamashita, Tatsuya Yamashita, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2016
Myeloid-derived suppressor cells correlate with patient outcomes in hepatic arterial infusion chemotherapy for hepatocellular carcinomaEishiro Mizukoshi, Tatsuya Yamashita, Kuniaki Arai, et al.
Journal of Virology|March 29, 2003
Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzeesMichelina Nascimbeni, Eishiro Mizukoshi, Markus Bosmann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 7, 2018
Immune response to human telomerase reverse transcriptase-derived helper T cell epitopes in hepatocellular carcinoma patientsMasashi Kumagai, Eishiro Mizukoshi, Toshikatsu Tamai, et al.
Pageof 17

Showing results (21-30 of 164) with videos related to

Sort By:
Pageof 17
International Journal of Cancer|September 10, 2009
Enhancement of tumor-specific T-cell responses by transcatheter arterial embolization with dendritic cell infusion for hepatocellular carcinomaEishiro Mizukoshi, Yasunari Nakamoto, Kuniaki Arai, et al.
Cancer Research|July 29, 2010
Antitumor effect after radiofrequency ablation of murine hepatoma is augmented by an active variant of CC Chemokine ligand 3/macrophage inflammatory protein-1alphaNoriho Iida, Yasunari Nakamoto, Tomohisa Baba, et al.
Journal of Gastroenterology|November 27, 2004
An open-label study of administration of EH0202, a health-food additive, to patients with chronic hepatitis CKyosuke Kaji, Satoshi Yoshida, Nobuo Nagata, et al.
Hepatology (Baltimore, Md.)|May 27, 2006
Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinomaEishiro Mizukoshi, Yasunari Nakamoto, Yohei Marukawa, et al.
Metabolism: Clinical and Experimental|November 14, 2007
Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virusYuki Kita, Eishiro Mizukoshi, Toshinari Takamura, et al.
Cancer Letters|September 2, 2015
Phase I trial of multidrug resistance-associated protein 3-derived peptide in patients with hepatocellular carcinomaEishiro Mizukoshi, Hidetoshi Nakagawa, Masaaki Kitahara, et al.
BMC Cancer|April 17, 2013
Peretinoin, an acyclic retinoid, improves the hepatic gene signature of chronic hepatitis C following curative therapy of hepatocellular carcinomaMasao Honda, Taro Yamashita, Tatsuya Yamashita, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2016
Myeloid-derived suppressor cells correlate with patient outcomes in hepatic arterial infusion chemotherapy for hepatocellular carcinomaEishiro Mizukoshi, Tatsuya Yamashita, Kuniaki Arai, et al.
Journal of Virology|March 29, 2003
Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzeesMichelina Nascimbeni, Eishiro Mizukoshi, Markus Bosmann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 7, 2018
Immune response to human telomerase reverse transcriptase-derived helper T cell epitopes in hepatocellular carcinoma patientsMasashi Kumagai, Eishiro Mizukoshi, Toshikatsu Tamai, et al.
Pageof 17